Your AI-Trained Oncology Knowledge Connection!

Fabio Puglisi

Articles by Fabio Puglisi

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial

ByNicholas McAndrew,Stephen Chia,Fabio Puglisi,Aditya Bardia, MD, MPH,Yann Izarzugaza,Christian Schem, MD,Binghe Xu,Fanny Le Du,Priyanka Sharma, MD,Karen Afenjar,Murat Akdere,Juan Pablo Zarate,Yogesh Chattar,Peter A. Fasching

June 23rd 2025

Latest Updated Articles

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial
Published: June 23rd 2025 | Updated:

Trending on CancerNetwork

T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup

Certepetide/FOLFIRINOX Displays Encouraging Preliminary Feasibility in PDAC

FDA Advises Against BLA for Novel Vaccine Combo/Pembrolizumab in Melanoma

Introductions and an Overview of Multiple Myeloma Treatments

Discussing Current Gaps in Multiple Myeloma Care

© 2025 MJH Life Sciences^®

All rights reserved.